Is the system rigged against drugs for newly-diagnosed cancers

Jul 29, 2015, 00:00 by Michael Croft

Boston Business Journal | Researchers from the Massachusetts Institute of Technology says current systems make pharmaceutical firms "underinvest" in early-stage cancer drugs.

July 29, 2015 | Researchers from the Massachusetts Institute of Technology says current systems make pharmaceutical firms "underinvest" in early-stage cancer drugs. Boston Business Journal